Companies in the genetics sector developing innovative solutions and technologies.
Explore 345 recently funded genetics companies with verified founder contact information and fundraising data.
Encoded Therapeutics is a biotechnology company developing genetic medicines for neurological disorders and other diseases.
Navion Neurosciences is a pre-clinical stage biotechnology company that develops sodium channel therapeutics for neurological diseases.
Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.
OutSee creates cutting-edge computational methods for genomics for the development of therapeutic targets and precision medicine.
Cloverleaf Bio develops an RNA therapeutic platform for oncology.
Yngvi Bio develops protein-based biopesticides for targeted agricultural pest control.
Ohmic Biosciences uses protein engineering technology in providing solutions to any disease in any crop.
Tektite Genome is an AI-driven genomics Biotech company that develops and represents non-toxic products and services.
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
Science4Beauty develops and sells conotoxin-based skincare products and provides biotechnology services.
Full Genomes uses sequencing technology to provide services such as reports on a customer's ancestry, genealogy, and family history.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Nionyx Bio builds AAV-based gene therapies to address some of the most potent kidney genetic diseases.
Regel Therapeutics provides gene therapy that significantly improve the lives of people with life-threatening genetic illnesses.
Lifebit CloudOS is the intelligent genomics platform that is the industry standard for unified, secure research over distributed big data.
Arcturus Therapeutics is a clinical-stage company specializing in mRNA medicines and vaccines.
Redefining Sample Preparation, Revolutionizing Genomics
Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.
iPremom is a healthcare technology company that develops molecular diagnostics for the early detection of pregnancy complications.
Primrose Bio is a biotechnology company that focuses on discovery, development, and manufacturing of new molecules.
Nvelop Therapeutics is a biotechnology company that developes genetic medicines for patients with severe genetic diseases.
Preclinical biotech with deep expertise in functional genomics to map genetic variants and advance a rare disease pipeline led by CB-001.
ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies
The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 345 genetics companies tracked in the VCBacked database.
Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked